Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innova Captab is an integrated pharmaceutical company based in India, specializing in the development, manufacturing, and marketing of a diverse range of generic formulations. The company operates as a leading Contract Development and Manufacturing Organization (CDMO), providing services to major Indian and global pharmaceutical firms such as Cipla, Glenmark, and Abbott. Its product portfolio includes various dosage forms, including tablets, capsules, dry syrups, and injections, across therapeutic areas like anti-infectives, analgesics, and cardiovascular health. Innova Captab maintains state-of-the-art manufacturing facilities in Baddi and Jammu, and recently expanded its capabilities through the acquisition of Sharon Bio-Medicine. The company is publicly traded on the NSE and BSE and is recognized for its strong R&D focus and extensive export network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovacorporate.